Valiant Organics Q2 FY25 earnings call: Revenue & Margins
Q2 FY25 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹160Cr
- −21.2% YoY
- −4.8% QoQ
- Net profit
- −₹12Cr
- Q2 FY24: ₹5 Cr
- Margin
- 0.5%
- −7.5 pp YoY
- −8.5 pp QoQ
Top 10 Chemicals & Petrochemicals companies on management guidance
See the sector's top 10 — free with your mobile number.
Based on Valiant Organics Ltd's Q2 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q2-FY25 Revenue from Operations: - Consolidated: INR 1,602 Mn (down 21.1% YoY from INR 2,031 Mn in Q2-FY24) - Standalone: INR 1,602 Mn (down 12.2% YoY from INR 1,825 Mn in Q2-FY24) - Sales Volume: - Overall sales volume declined by 6% in Q2-FY25 (Page 10) - Specific chemistry volume trends (in metric tons) for Q2-FY25 vs Q2-FY24: - Chlorination: 730 MT vs 894 MT - Hydrogenation: 479 MT vs 660 MT - Ammonolysis: 118 MT vs 136 MT - Others: 221 MT vs 348 MT - Outlook: - Q2-FY25 Consolidated Financials (Page 9 & 12): - EBITDA: INR 24 Mn, down 84.5% YoY from INR 155 Mn - Operating EBITDA Margin: 1.5%, down 613 bps YoY from 7.63% - Profit After Tax (PAT): INR (125) Mn, compared to PAT of INR 47 Mn YoY (loss vs profit) - PAT Margin: (7.80)%, down significantly from 2.31% - Q2-FY25 Standalone Financials (Page 14): - EBITDA: INR 23 Mn, down 86.7% YoY from INR 173 Mn - Operating EBITDA Margin: 1.44%, down 804 bps YoY from 9.48% - PAT: INR (112) Mn, down from INR 39 Mn YoY (loss vs profit) - PAT Margin: (6.99)%, down from 2.14% - Explicit Margin Outlook:
From Valiant Organics Ltd's Q2 FY25 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q2-FY25 Revenue from Operations:
- Consolidated: INR 1,602 Mn (down 21.1% YoY from INR 2,031 Mn in Q2-FY24)
- Standalone: INR 1,602 Mn (down 12.2% YoY from INR 1,825 Mn in Q2-FY24)
- Sales Volume:
- Overall sales volume declined by 6% in Q2-FY25 (Page 10)
- Specific chemistry volume trends (in metric tons) for Q2-FY25 vs Q2-FY24:
- Chlorination: 730 MT vs 894 MT
- Hydrogenation: 479 MT vs 660 MT
- Ammonolysis: 118 MT vs 136 MT
- Others: 221 MT vs 348 MT
2 more points from Valiant Organics Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Valiant Organics Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
See what Valiant Organics Ltd said on capital expenditure plans — free account, 30 seconds.
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Valiant Organics Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Valiant Organics Ltd said on order book & pipeline — free account, 30 seconds.
Valiant Organics Ltd — Quarterly revenue & net profit
Valiant Organics Ltd Q2 FY25 results — key figures
| ₹ Cr | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue | 160 | 203 | -21.2% | 168 | -4.8% |
| Operating profit (EBITDA) | 1 | 15 | -93.3% | 16 | -93.7% |
| Operating margin | 0.5% | 8% | -7.5 pp | 9% | -8.5 pp |
| Profit before tax | -14 | 6 | -333.3% | 2 | -800% |
| Net profit (PAT) | -12 | 5 | -340% | -1 | — |
| EPS (₹) | -4.63 | 1.58 | -393% | -0.22 | — |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹304 Cr, net profit ₹17 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Valiant Organics's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Himadri Special (Q2 FY25)
1,135.21 Cr, up 13.01% YoY (Page 45) . Key concall takeaways from Himadri Speciality Chemical Ltd's Q2 FY25 earnings call — and how it ranks against sector…
- Vidhi Specialty (Q2 FY25)
Year-on-Year (Y-o-Y) growth: 13.9% (Page 8) . Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q2 FY25 earnings call — and how it ranks…
- Chemcon Speciality Chemicals (Q2 FY25)
30% YoY). Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q2 FY25 earnings call — and how it ranks against sector peers.
- Excel Industries (Q2 FY25)
Q2 FY25 standalone revenue from operations: ₹269 crore, up 1.51% QoQ from Q1 FY25 (₹265 crore). Key concall takeaways from Excel Industries Ltd's Q2 FY25…
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Valiant Organics Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Valiant Organics Ltd Q2 FY25 results?
Q2-FY25 Revenue from Operations: - Consolidated: INR 1,602 Mn (down 21.1% YoY from INR 2,031 Mn in Q2-FY24) - Standalone: INR 1,602 Mn (down 12.2% YoY from INR 1,825 Mn in Q2-FY24) - Sales Volume: - Overall sales volume declined by 6% in Q2-FY25 (Page 10) - Specific chemistry volume trends (in metric tons) for Q2-FY25 vs Q2-FY24: - Chlorination: 730 MT vs 894 MT - Hydrogenation: 479 MT vs 660 MT - Ammonolysis: 118 MT vs 136 MT - Others: 221 MT vs 348 MT - Outlook: - Q2-FY25 Consolidated Financials (Page 9 & 12): - EBITDA: INR 24 Mn, down 84.5% YoY from INR 155 Mn - Operating EBITDA Margin: 1.5%, down 613 bps YoY from 7.63% - Profit After Tax (PAT): INR (125) Mn, compared to PAT of INR 47 Mn YoY (loss vs profit) - PAT Margin: (7.80)%, down significantly from 2.31% - Q2-FY25 Standalone Financials (Page 14): - EBITDA: INR 23 Mn, down 86.7% YoY from INR 173 Mn - Operating EBITDA Margin: 1.44%, down 804 bps YoY from 9.48% - PAT: INR (112) Mn, down from INR 39 Mn YoY (loss vs profit) - PAT Margin: (6.99)%, down from 2.14% - Explicit Margin Outlook:
What is Valiant Organics Ltd share price analysis?
Valiant Organics Ltd currently shows a neutral. The stock trades at a P/E of 23.7 with a market cap of ₹1,196 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Valiant Organics Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
